Cargando…
From MAFLD to hepatocellular carcinoma and everything in between
Metabolic (dysfunction) associated fatty liver disease (MAFLD), previously known as non-alcoholic fatty liver disease, is the most common cause of chronic liver disease worldwide. Many risk factors contribute to the pathogenesis of MAFLD with metabolic dysregulation being the final arbiter of its de...
Autores principales: | Bae, Sarah Da Won, George, Jacob, Qiao, Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920461/ https://www.ncbi.nlm.nih.gov/pubmed/35191421 http://dx.doi.org/10.1097/CM9.0000000000002089 |
Ejemplares similares
-
MAFLD: How is it different from NAFLD?
por: Gofton, Cameron, et al.
Publicado: (2023) -
MAFLD: an optimal framework for understanding liver cancer phenotypes
por: Crane, Harry, et al.
Publicado: (2023) -
Impact of MAFLD on the complications after hepatectomy in patients with HBV-related hepatocellular carcinoma
por: Xiong, Ke-Gong, et al.
Publicado: (2023) -
Role of Insulin Resistance in MAFLD
por: Sakurai, Yoshitaka, et al.
Publicado: (2021) -
MAFLD and Celiac Disease in Children
por: Scapaticci, Serena, et al.
Publicado: (2023)